France Immunohistochemistry Market Size & Outlook
France immunohistochemistry market, 2018-2030 (US$M)
Related Markets
France immunohistochemistry market highlights
- The France immunohistochemistry market generated a revenue of USD 98.5 million in 2023 and is expected to reach USD 149.7 million by 2030.
- The France market is expected to grow at a CAGR of 6.2% from 2024 to 2030.
- In terms of segment, antibodies was the largest revenue generating product in 2023.
- Antibodies is the most lucrative product segment registering the fastest growth during the forecast period.
Immunohistochemistry market data book summary
| Market revenue in 2023 | USD 98.5 million |
| Market revenue in 2030 | USD 149.7 million |
| Growth rate | 6.2% (CAGR from 2023 to 2030) |
| Largest segment | Antibodies |
| Fastest growing segment | Antibodies |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Antibodies, Reagents, Equipment, Kits |
| Key market players worldwide | Thermo Fisher Scientific Inc, Roche Holding AG, Merck KGaA, Danaher Corp, PerkinElmer, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Abcam PLC, Cell Signaling Technology, Bio SB |
Other key industry trends
- In terms of revenue, France accounted for 4.2% of the global immunohistochemistry market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany immunohistochemistry market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 216.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Immunohistochemistry Market Scope
Immunohistochemistry Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
France immunohistochemistry market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to immunohistochemistry market will help companies and investors design strategic landscapes.
Antibodies was the largest segment with a revenue share of 42.03% in 2023. Horizon Databook has segmented the France immunohistochemistry market based on antibodies, reagents, equipment, kits covering the revenue growth of each sub-segment from 2018 to 2030.
Increasing initiatives by local players for development and launch of novel IHC solutions is anticipated to support regional growth. For instance, in October 2018, HalioDx, a French immuno-oncology diagnostic company, introduced its new product Brightplex, a high-capacity IHC multiplex technology that can enable analysis of several biomarkers on a single FFPE slide.
Furthermore, according to International Diabetes Federation, there were 3,480,000 diabetes cases in France in 2019. It stated that diabetes prevalence in adults was recorded at 7.6% in that year. IHC is used to detect abnormal cells in beta cell-induced diabetes, thus driving the market.
Reasons to subscribe to France immunohistochemistry market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of France immunohistochemistry market databook
-
Our clientele includes a mix of immunohistochemistry market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the France immunohistochemistry market , including forecasts for subscribers. This country databook contains high-level insights into France immunohistochemistry market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
France immunohistochemistry market size, by product, 2018-2030 (US$M)
France Immunohistochemistry Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
